WNT Signaling in Cancer Immunosurveillance
Deregulated WNT signaling has been shown to favor malignant transformation, tumor progression, and resistance to conventional cancer therapy in a variety of preclinical and clinical settings. Accumulating evidence suggests that aberrant WNT signaling may also subvert cancer immunosurveillance, hence...
Main Author: | Spranger, Stefani |
---|---|
Other Authors: | Massachusetts Institute of Technology. Department of Biology |
Format: | Article |
Language: | English |
Published: |
Elsevier BV
2020
|
Online Access: | https://hdl.handle.net/1721.1/124940 |
Similar Items
-
Epithelial-to-mesenchymal transition hinders interferon-γ-dependent immunosurveillance in lung cancer cells
by: Tseng, Po-Chun, et al.
Published: (2022) -
Casting a wider net: Immunosurveillance by nonclassical MHC molecules
by: Birnbaum, Michael E.
Published: (2020) -
Insights from immuno-oncology: the Society for Immunotherapy of Cancer Statement on access to IL-6-targeting therapies for COVID-19
by: Spranger, Stefani
Published: (2020) -
Modulation of the immune microenvironment by tumor-intrinsic oncogenic signaling
by: Nguyen, Kim Bich, et al.
Published: (2021) -
Relationships between Wnt-Notch-Hippo signaling pathways and their relevance to colorectal cancer pathogenesis
by: Chai, Boon Lee
Published: (2018)